Lurasidone‐induced hyperosmolar hyperglycemic syndrome: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12259
Abstract: Lurasidone has few metabolic adverse effects and is recommended as an alternative when other antipsychotic drugs considerably increase body weight or blood sugar concentrations. read more here.
Keywords: hyperosmolar hyperglycemic; lurasidone induced; induced hyperosmolar; lurasidone ... See more keywords
Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
Sign Up to like & getrecommendations! Published in 2018 at "Indian Journal of Psychological Medicine"
DOI: 10.4103/ijpsym.ijpsym_374_17
Abstract: The U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application Lurasidone (Latuda, Sunovion Pharmaceuticals), an atypical antipsychotic, for the treatment of schizophrenia in adolescents 13–17 years of age. Lurasidone was previously… read more here.
Keywords: thrombocytopenia signal; myelosuppression; drug; induced thrombocytopenia ... See more keywords